Loading
MH
MedAvail Holdings, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by ABG WTT-MedAvail Ltd, was filed 06 Apr 2022.
MedAvail Holdings, Inc.: what insiders have been doing
MedAvail Holdings, Inc., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SEC (Form 4). No insider at MedAvail Holdings, Inc. has published a filing in the past twelve months. The most recent one dates from 2 October 2023.
Over the whole record (from 2016), the tally stands at 62 purchases and 5 sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
99
Thresholds
n/a
Buy Volume
€18M
62 ops. · all time
Sell Volume
€32,421
5 ops. · all time
Since the insiders bought
- -80.8%Entry US$70.50 · Close at T+365 US$13.54
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2022FY ended December 2022 · cache
US$0.00
Analyst consensus
Income statement
RevenueUS$43.1M
Gross profitUS$2.6M6% margin
EBITDA-US$41.8M-97% margin
Net income-US$47.6M-106.2% margin
Valuation
P/Book0.0x
Beta-125.58
Balance sheet & cash
Total debtUS$7.1M
Free Cash Flow-US$50M
Debt / Equity10%
Profitability & ownership
ROE-194.7%
ROA-68.1%
% institutions0.0%
Last declaration on 2 October 2023
Declarations99 total
303 shares@ US$5.70Common StockSEC:0001879971-23-000002:1
680 shares0Common StockSEC:0001879971-23-000002:0
3,287 shares@ US$0.30730.6% of flowCommon StockSEC:0001209191-23-020849:0
72,785 shares@ US$0.3112Common StockSEC:0001209191-23-016982:1
20,773 shares@ US$0.3262100.0% of flowCommon StockSEC:0001209191-23-016982:0
6,727 shares@ US$0.336669.4% of flowCommon StockSEC:0001209191-23-016983:0
20,000 shares0Common StockSEC:0001209191-23-016101:1
8,333 shares0Common StockSEC:0001209191-23-016101:0
282,259 shares0Common StockSEC:0001209191-23-016100:0
7,639,117 shares@ US$1.0625Common StockSEC:0001104659-22-077763:1
9,411,765 shares@ €1.014141.1% of flowCommon StockSEC:0001104659-22-077763:0
2,974,117 shares@ US$1.0625Common StockSEC:0000899243-22-014088:1
Canonical exit: 3 Jul 2022 (T+90)
14,117,646 shares@ €0.968100.0% of flowCommon StockSEC:0001104659-22-043369:0
11,143,529 shares@ US$1.0625100.0% of flowCommon StockSEC:0000899243-22-014088:0
Canonical exit: 3 Jul 2022 (T+90)
6,943 shares@ US$14.9959Common StockSEC:0000899243-21-000379:0
Canonical exit: 31 Mar 2021 (T+90)
5,727 shares@ US$14.9959Common StockSEC:0000899243-21-000379:1
Canonical exit: 31 Mar 2021 (T+90)
3,894 shares@ US$13.9766Common StockSEC:0000899243-20-035506:0
Canonical exit: 28 Mar 2021 (T+90)
3,213 shares@ US$13.9766Common StockSEC:0000899243-20-035506:1
Canonical exit: 28 Mar 2021 (T+90)
55 shares@ US$14.00Common StockSEC:0000899243-20-035506:2
Canonical exit: 29 Mar 2021 (T+90)
45 shares@ US$14.00Common StockSEC:0000899243-20-035506:3
Canonical exit: 29 Mar 2021 (T+90)
9,287 shares@ US$13.7016Common StockSEC:0000899243-20-035198:0
Canonical exit: 22 Mar 2021 (T+90)
7,661 shares@ US$13.7016Common StockSEC:0000899243-20-035198:1
Canonical exit: 22 Mar 2021 (T+90)
11,890 shares@ US$13.9865Common StockSEC:0000899243-20-035198:2
Canonical exit: 23 Mar 2021 (T+90)
9,810 shares@ US$13.9865Common StockSEC:0000899243-20-035198:3
Canonical exit: 23 Mar 2021 (T+90)
4,871 shares@ US$13.9919Common StockSEC:0000899243-20-035198:4
Canonical exit: 24 Mar 2021 (T+90)
25 of 99 declarations
About MedAvail Holdings, Inc.
MedAvail Holdings, Inc. is a healthcare technology company that provides innovative solutions for medication dispensing. It primarily operates on the XNAS stock market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
